CSCI
Price:
$2.04
Market Cap:
$6.43M
COSCIENS Biopharma Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests in Canada, Switzerland, Ireland, Denmark, Germany, the United States, and internationally. Its lead product is Macrilen (macimorelin), an orally available peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a for the diagnosis of patients with adult growth hormone deficiency and childhood-onset growth hormone deficiency, as well as endocrinology and oncology indications; AEZS-150, a delayed clearance parathyroid hormone fusion polypeptide that is in preclinical trial for the treatment ...[Read more]
Industry
Biotechnology
IPO Date
1996-07-18
Stock Exchange
NASDAQ
Ticker
CSCI
According to COSCIENS Biopharma Inc.’s latest financial reports and current stock price. The company's current ROE is -149.40%. This represents a change of 288.37% compared to the average of -38.47% of the last 4 quarters.
The mean historical ROE of COSCIENS Biopharma Inc. over the last ten years is -3.07%. The current -149.40% ROE has changed 4.77% with respect to the historical average. Over the past ten years (40 quarters), CSCI's ROE was at its highest in in the December 2015 quarter at 43.20%. The ROE was at its lowest in in the December 2024 quarter at -51.14%.
Average
-3.07%
Median
3.14%
Minimum
-116.32%
Maximum
62.49%
Discovering the peaks and valleys of COSCIENS Biopharma Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 602.10%
Maximum Annual ROE = 62.49%
Minimum Annual Increase = -250.41%
Minimum Annual ROE = -116.32%
| Year | ROE | Change |
|---|---|---|
| 2024 | -116.32% | 602.10% |
| 2023 | -16.57% | -214.32% |
| 2022 | 14.49% | 19.37% |
| 2021 | 12.14% | 59.01% |
| 2020 | 7.64% | -250.41% |
| 2019 | -5.08% | 273.48% |
| 2018 | -1.36% | -68.02% |
| 2017 | -4.25% | -126.30% |
| 2016 | 16.16% | -74.14% |
| 2015 | 62.49% | -17.97% |
The current ROE of COSCIENS Biopharma Inc. (CSCI) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-39.47%
5-year avg
-19.72%
10-year avg
-3.07%
COSCIENS Biopharma Inc.’s ROE is less than Biora Therapeutics, Inc. (12.18%), greater than Turnstone Biologics Corp. (-171.86%), greater than CervoMed Inc. (-59.15%), less than Channel Therapeutics Corporation (243.75%), greater than Tvardi Therapeutics, Inc. (-115.90%), greater than Omega Therapeutics, Inc. (-173.25%), greater than TNF Pharmaceuticals, Inc. (-48.34%), less than Apexigen, Inc. (48.27%), greater than IMV Inc. (-489.29%), less than Kineta, Inc. (71.50%),
| Company | ROE | Market cap |
|---|---|---|
| 12.18% | $994.99K | |
| -171.86% | $8.21M | |
| -59.15% | $83.83M | |
| 243.75% | $8.90M | |
| -115.90% | $39.21M | |
| -173.25% | $7.90M | |
| -48.34% | $9.18M | |
| 48.27% | $9.57M | |
| -489.29% | $117.00 | |
| 71.50% | $7.05M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like COSCIENS Biopharma Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like COSCIENS Biopharma Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is COSCIENS Biopharma Inc.'s ROE?
How is the ROE calculated for COSCIENS Biopharma Inc. (CSCI)?
What is the highest ROE for COSCIENS Biopharma Inc. (CSCI)?
What is the 3-year average ROE for COSCIENS Biopharma Inc. (CSCI)?
What is the 5-year average ROE for COSCIENS Biopharma Inc. (CSCI)?
How does the current ROE for COSCIENS Biopharma Inc. (CSCI) compare to its historical average?